Jill Wechsler

Jill Wechsler is ACT's Washington Editor

Articles

FDA Inspection “Roadmap” Acknowledges Continued Delays and Challenges Ahead

May 12, 2021

FDA expects to conduct only a small portion of scheduled facility visits in 2021 due to continued limitations on travel imposed by the COVID-19 pandemic.

Pharma Prices & Patents Under Attack

May 06, 2021

The drive for “vaccine equity” around the world is bolstering efforts to limit patent protections on innovative medicines and vaccines to combat the global pandemic.

FDA Gets Tough on Sponsors Not Reporting Clinical Trial Results

April 30, 2021

Sponsors ignoring FDA requirements will now face stricter penalties.

Biden Seeks Added Funding for Medical Research, Disease Tracking

April 22, 2021

White House’s summary of “topline” funding requests this month continues efforts to combat coronavirus pandemic and to restore the nation’s economic health.